Autopsy report · NCT00907413

Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma

“PI relocated and reopened trial in new university”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 1 year 1 month before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Cholangiocarcinoma

Interventions

ERCP and Photodynamic Therapy; ERCP only

Participants

50

Sites

1

Countries

United States

Trials that died the same way

• Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
  “The PI left the Institution and sponsor decided to close the trial.” (72% match in meaning)
• Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
  “PI relocated to another Institution” (71% match in meaning)
• Complex Spine Enhanced Recovery After Surgery (ERAS)
  “PI moved to different institution” (67% match in meaning)
• High-intensity Exercise After Treatment
  “Original PI moved to a new institution” (67% match in meaning)
• Ultra High Field MRI of Focal Pediatric Epilepsy
  “PI moved to a different institution.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.